- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Advance Non-small Cell Lung Cancer in United Kingdom
Total 4290 results
-
Cancer Research UKCompletedAdvanced Non-small Cell Lung CancerUnited Kingdom
-
Cancer Research UKBicycle TherapeuticsCompletedNon-Small Cell Lung Cancer | Advanced Solid Tumours | Oesophageal Cancer | Non-Small Cell Lung SarcomaUnited Kingdom
-
Institute of Cancer Research, United KingdomMerck Sharp & Dohme LLC; Merck Serono GmbH, GermanyRecruitingNon Small Cell Lung Cancer | Advanced CancerUnited Kingdom
-
Achilles Therapeutics UK LimitedTerminatedMelanoma | Advanced Non Small Cell Lung CancerUnited Kingdom
-
Mythic TherapeuticsRecruitingNon-Small Cell Lung Cancer | NSCLC | Advanced Non-Small Cell Lung Cancer | NSCLC Stage IV | NSCLC Stage IIIB | Advanced Non-Small Cell Squamous Lung Cancer | Advanced Non-Small Cell Non-Squamous Lung CancerUnited States, Australia, Korea, Republic of, United Kingdom
-
AstraZenecaCompletedAdvanced Non Small Cell Lung Cancer | Advanced (Inoperable) Non Small Cell Lung CancerFrance, Korea, Republic of, United Kingdom, Spain
-
Lisette NixonCompletedLocally Advanced Non-small Cell Lung CancerUnited Kingdom
-
AstraZenecaCompletedAdvanced Non Small Cell Lung Cancer | Advanced (Inoperable) Non Small Cell Lung CancerBelgium, United States, Korea, Republic of, Taiwan, United Kingdom, Netherlands
-
University Hospital Southampton NHS Foundation...Royal Bournemouth and Christchurch Hospitals NHS Foundation TrustUnknownNon Small Cell Lung Cancer | Non Small Cell Lung Cancer Stage IIIB | Non Small Cell Lung Cancer MetastaticUnited Kingdom
-
University of OxfordCancer Research UK; Guy's and St Thomas' NHS Foundation Trust; NHS Lothian; National... and other collaboratorsCompletedLocally Advanced Non-Small Cell Lung CancerUnited Kingdom
-
BayerRecruitingHealthy Volunteers | Advanced Non-small Cell Lung Cancer | EGFR Mutation | HER2 MutationUnited Kingdom
-
Royal Marsden NHS Foundation TrustBristol-Myers SquibbActive, not recruitingNon-small Cell Lung Cancer Stage I | Non-small Cell Lung Cancer Stage IIUnited Kingdom
-
AstraZenecaCompletedAdvanced Non Small Cell Lung Cancer | Advanced (Inoperable) Non Small Cell Lung CancerUnited States, France, Germany, Korea, Republic of, Taiwan, United Kingdom, Spain, Italy, Japan, Australia
-
Eli Lilly and CompanyWithdrawnMetastatic Squamous Non-Small Cell Lung Cancer | Locally Advanced Squamous Non-Small Cell Lung CancerItaly, Romania, Germany, Belgium, Russian Federation, United States, United Kingdom
-
Boehringer IngelheimCompletedNon-squamous, Non-Small Cell Lung CancerUnited Kingdom
-
QIAGEN Gaithersburg, IncAmgenActive, not recruitingNon Small Cell Lung CancerUnited Kingdom
-
Gilead SciencesArcus Biosciences, Inc.RecruitingLung Cancer | Advanced or Metastatic Non-Small-Cell Lung Cancer | Resectable Non-Small-Cell Lung CancerUnited States, Korea, Republic of, Taiwan, Hong Kong, Israel, United Kingdom
-
QIAGEN Gaithersburg, IncAmgenActive, not recruitingNon-small Cell Lung CancerUnited Kingdom
-
Achilles Therapeutics UK LimitedRecruitingAdvanced Non Small Cell Lung CancerUnited States, Spain, Germany, France, United Kingdom
-
The Christie NHS Foundation TrustAstraZeneca; University of ManchesterCompleted
-
AstraZenecaCompletedNon-small-cell Lung CancerUnited Kingdom
-
University of HullHull University Teaching Hospitals NHS TrustWithdrawnLung Cancer | Non-small Cell Lung CancerUnited Kingdom
-
Oxford University Hospitals NHS TrustNational Institute for Health Research, United KingdomCompleted
-
Royal Marsden NHS Foundation TrustUnknownNon-small Cell Lung CancerUnited Kingdom
-
University College, LondonCancer Research UKRecruitingSmall Cell Lung Cancer | Lung Cancer, Non-small Cell | Pleural MesotheliomaUnited Kingdom
-
Agenus Inc.CompletedLung Cancer | Non-Small-Cell Lung Carcinoma | Pulmonary CancerUnited Kingdom
-
Liverpool Heart and Chest Hospital NHS Foundation...WithdrawnNon Small Cell Lung Cancer | Aspirin | SurvivalUnited Kingdom
-
Royal Marsden NHS Foundation TrustMerck Sharp & Dohme LLCTerminatedMetastatic Non-small-cell lunG CancerUnited Kingdom
-
European Organisation for Research and Treatment...Active, not recruitingEGFR Mutation Positive Non Small Cell Lung CancerUnited Kingdom
-
Arcus Biosciences, Inc.Gilead SciencesRecruitingAdvanced Non-Small Cell Lung CancerUnited States, Korea, Republic of, Australia, United Kingdom, Taiwan, Spain
-
Gradalis, Inc.WithdrawnLung Neoplasms | Advanced Non-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerUnited States
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerNetherlands, United Kingdom
-
Cancer Research UKAstraZenecaCompletedCancer | Non Small Cell Lung CancerUnited Kingdom
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyCompletedNon-small Cell Lung Cancer | Advanced Non-small Cell Lung Cancer | Recurrent Non-small Cell Lung CancerUnited States
-
Eli Lilly and CompanyCompletedNon-Small Cell Lung Cancer Metastatic | Nonsquamous Non-Small Cell Neoplasm of Lung | Non-Small Cell Lung Cancer Stage IIIBUnited Kingdom, Sweden
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)CompletedStage IIIA Non-small Cell Lung Cancer | Stage IIIB Non-small Cell Lung Cancer | Extensive Stage Small Cell Lung Cancer | Recurrent Small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer | Healthy, no Evidence of Disease | Limited Stage Small Cell Lung... and other conditionsUnited States
-
European Organisation for Research and Treatment...UnknownNon-small Cell Lung Cancer Stage I | Non-small Cell Lung Cancer Stage IIGermany, Belgium, United Kingdom, Switzerland
-
AstraZenecaCompletedLocally Advanced or Metastatic NSCL Cancer Stage IIIB IVUnited Kingdom
-
M.D. Anderson Cancer CenterMirati Therapeutics Inc.RecruitingAdvanced Solid Tumor | Non-small Cell Lung CancersUnited States
-
AstraZenecaCompletedNon-Small Cell Lung Cancer | Advanced Solid TumoursUnited States, United Kingdom
-
Daiichi SankyoAstraZenecaAvailableAdvanced Non-Small Cell Lung Cancer | Metastatic Non Small Cell Lung CancerUnited States
-
University of ChicagoGenentech, Inc.CompletedAdvanced Non-squamous Non-Small Cell Lung CancerUnited States
-
Mirati Therapeutics Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung CancerUnited States, Korea, Republic of, Italy, Spain, Czechia, Hungary, Netherlands, Canada, Australia, Austria, Belgium, Germany, Ireland, Israel, Poland, United Kingdom, Taiwan, Portugal
-
Prof Corinne Faivre-FinnRoyal Marsden NHS Foundation Trust; The Leeds Teaching Hospitals NHS Trust; Cambridge... and other collaboratorsCompletedNon Small Cell Lung CancerUnited Kingdom
-
University College, LondonHoffmann-La RocheActive, not recruitingNon-small Cell Lung CancerUnited Kingdom
-
Dartmouth-Hitchcock Medical CenterCTI BioPharmaCompletedAdvanced Non-small Cell Lung CancerUnited States
-
ArriVent BioPharma, Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung Cancer | Non-Small Cell Lung Cancer (NSCLC) | HER2 Exon 20 Mutations | EGFR Exon 20 Mutations | EGFR Uncommon Mutations, Including G719X and S768IUnited States, Australia, Spain, United Kingdom, France, Italy, China, Korea, Republic of, Canada, Japan, Netherlands
-
National Cancer Institute (NCI)CompletedNon-Small-Cell Lung Carcinoma | Cancers of Non-thoracic Origin With Metastases to the Lungs or Pleura | Advanced Esophageal Cancers | Primary Small Cell Lung Cancers | Pleural MesotheliomasUnited States
-
Daiichi Sankyo, Inc.CompletedNSCLC (Advanced Non-small Cell Lung Cancer)Ukraine, United Kingdom, United States, Bulgaria, Belgium, Germany, Hungary, Austria, Italy, Israel, Lithuania, Romania, Slovenia
-
GlaxoSmithKlineCompletedLung Cancer, Non-Small CellUnited States, United Kingdom